BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 31050922)

  • 21. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
    Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
    Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of loop-mediated isothermal amplification assay for detection and typing of human papilloma virus 16 and 18 from endocervical samples.
    Mudhigeti N; Kalawat U; Hulikal N; Kante M
    Indian J Med Microbiol; 2019; 37(2):241-247. PubMed ID: 31745026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
    Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
    Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women.
    Uberti-Foppa C; Origoni M; Maillard M; Ferrari D; Ciuffreda D; Mastrorilli E; Lazzarin A; Lillo F
    J Med Virol; 1998 Oct; 56(2):133-7. PubMed ID: 9746069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-vaccination prevalence and genotype distribution of human papillomavirus infection among women from urban Tunis: a cross-sectional study.
    Guettiti H; Ennaifer E; Attia L; Chelly D; Alaya NB; Aissa RB; Laassili T; Boubaker S
    Asian Pac J Cancer Prev; 2014; 15(21):9361-5. PubMed ID: 25422225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
    Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
    J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotypes distribution of human papillomavirus in cervical samples of Ecuadorian women.
    García Muentes GD; García Rodríguez LK; Burgos Galarraga RI; Almeida Carpio F; Ruiz Cabezas JC
    Rev Bras Epidemiol; 2016 Mar; 19(1):160-6. PubMed ID: 27167657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus and invasive cervical cancer in Brazil.
    Eluf-Neto J; Booth M; Muñoz N; Bosch FX; Meijer CJ; Walboomers JM
    Br J Cancer; 1994 Jan; 69(1):114-9. PubMed ID: 8286192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening programs in low-income communities. Experiences from Ecuador. Low cost detection of HPV infection in a developing country.
    Cecchini G; Paganini G; D'Amico M; Cannone M; Bertuletti C; Barberis MC
    Pathologica; 2009 Apr; 101(2):76-9. PubMed ID: 19886552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus: science and technologies for the elimination of cervical cancer.
    Bosch FX
    Expert Opin Pharmacother; 2011 Oct; 12(14):2189-204. PubMed ID: 21756205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of human papillomavirus infection in women with systemic sclerosis.
    Martin M; Mougin C; Prétet JL; Gil H; Meaux-Ruault N; Puzenat E; Ramanah R; Aubin F; Touzé A; Coursaget P; Jacquin E; Magy-Bertrand N
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-145-8. PubMed ID: 25151849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
    Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
    Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of human papillomavirus in women from Saudi Arabia.
    Turki R; Sait K; Anfinan N; Sohrab SS; Abuzenadah AM
    Asian Pac J Cancer Prev; 2013; 14(5):3177-81. PubMed ID: 23803100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus infection, cervical dysplasia and invasive cervical cancer in Honduras: a case-control study.
    Ferrera A; Velema JP; Figueroa M; Bulnes R; Toro LA; Claros JM; De Barahona O; Melchers WJ
    Int J Cancer; 1999 Sep; 82(6):799-803. PubMed ID: 10446444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.
    Moussavou-Boundzanga P; Koumakpayi IH; Labouba I; Leroy EM; Belembaogo E; Berthet N
    Virol J; 2017 Dec; 14(1):241. PubMed ID: 29268766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
    Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
    BMC Cancer; 2017 Nov; 17(1):791. PubMed ID: 29178896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
    Thomsen LT; Kjær SK
    BMC Med; 2021 Jul; 19(1):165. PubMed ID: 34261466
    [No Abstract]   [Full Text] [Related]  

  • 40. HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries.
    Ton M; Swami N; Germar MJV; Dee EC
    Int J Gynecol Cancer; 2022 Dec; 32(12):1632-1633. PubMed ID: 36220194
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.